{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:19:32Z","timestamp":1793225972306,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"grant from Health Commission of Zhejiang Province","award":["JBZX-202004"],"award-info":[{"award-number":["JBZX-202004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003272"],"award-info":[{"award-number":["82003272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073144"],"award-info":[{"award-number":["82073144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Huadong MedicineJoint Funds of the Zhejiang Provincial Natural Science Foundation of China","award":["LHDMD22H310005"],"award-info":[{"award-number":["LHDMD22H310005"]}]},{"name":"Research Unit Project of Chinese Academy of Medical Sciences","award":["2019-I2M-5-030"],"award-info":[{"award-number":["2019-I2M-5-030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is one of the most lethal tumor types worldwide. Glycosylation has shown promise in the study of tumor mechanisms and treatment. The glycosylation status of HCC and the underlying molecular mechanisms are still not fully elucidated. Using bioinformatic analysis we obtained a more comprehensive characterization of glycosylation of HCC. Our analysis presented that high glycosylation levels might correlate with tumor progression and poor prognosis. Subsequent Experiments identified key molecular mechanisms for ST6GALNAC4 promoting malignant progression by inducing abnormal glycosylation. We confirmed the contribution of ST6GALNAC4 to proliferation, migration, and invasion in vitro and in vivo. Mechanistic studies revealed that ST6GALNAC4 may be induced abnormal TGFBR2 glycosylation, resulting in the higher protein levels of TGFBR2 and TGF<jats:inline-formula><jats:alternatives><jats:tex-math>$$\\beta$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\"><mml:mi>\u03b2<\/mml:mi><\/mml:math><\/jats:alternatives><\/jats:inline-formula>pathway increased activation. Our study also provided a further understand of immunosuppressive function of ST6GALNAC4 through T antigen-galectin3+ TAMs axis. This study has provided one such possibility that galectin3 inhibitors might be an acceptable treatment choice for HCC patients with high T antigen expression.<\/jats:p>","DOI":"10.1186\/s12967-023-04191-7","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T02:01:59Z","timestamp":1688004119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation"],"prefix":"10.1186","volume":"21","author":[{"given":"Da","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongliang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6325-0766","authenticated-orcid":false,"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"4191_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"4191_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108\u201318.","journal-title":"Eur J Cancer."},{"key":"4191_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001624","volume":"11","author":"AG Singal","year":"2014","unstructured":"Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11: e1001624.","journal-title":"PLoS Med."},{"key":"4191_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13073-022-01055-5","volume":"14","author":"M Alvarez","year":"2022","unstructured":"Alvarez M, Benhammou JN, Darci-Maher N, French SW, Han SB, Sinsheimer JS, et al. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival. Genome Med. 2022;14:50.","journal-title":"Genome Med."},{"key":"4191_CR5","doi-asserted-by":"crossref","unstructured":"Hepatocellular carcinoma. Nat Revi Dise Primers. 2021; 7: 7.","DOI":"10.1038\/s41572-021-00245-6"},{"key":"4191_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki A. Biological roles of glycans. Glycobiology. 2017;27:3\u201349.","journal-title":"Glycobiology."},{"key":"4191_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/glycob\/cwr182","volume":"22","author":"EP Bennett","year":"2012","unstructured":"Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, Tabak LA. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2012;22:736\u201356.","journal-title":"Glycobiology."},{"key":"4191_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/glycob\/6.6.635","volume":"6","author":"H Clausen","year":"1996","unstructured":"Clausen H, Bennett EP. A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. Glycobiology. 1996;6:635\u201346.","journal-title":"Glycobiology."},{"issue":"Pt 1","key":"4191_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1042\/bj3520037","volume":"352","author":"A Harduin-Lepers","year":"2000","unstructured":"Harduin-Lepers A, Stokes DC, Steelant WF, Samyn-Petit B, Krzewinski-Recchi MA, Vallejo-Ruiz V, et al. Cloning, expression and gene organization of a human Neu5Ac alpha 2\u20133Gal beta 1\u20133GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV. Biochem J. 2000;352(Pt 1):37\u201348.","journal-title":"Biochem J."},{"key":"4191_CR10","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/2159-8290.CD-13-0760","volume":"5","author":"NE Reticker-Flynn","year":"2015","unstructured":"Reticker-Flynn NE, Bhatia SN. Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche. Cancer Discov. 2015;5:168\u201381.","journal-title":"Cancer Discov."},{"key":"4191_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.840388","volume":"13","author":"LY Chang","year":"2022","unstructured":"Chang LY, Liang SY, Lu SC, Tseng HC, Tsai HY, Tang CJ, et al. Molecular basis and role of Siglec-7 ligand expression on chronic lymphocytic leukemia B cells. Front Immunol. 2022;13: 840388.","journal-title":"Front Immunol."},{"key":"4191_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788431","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Geng R, Yang S, Shao F, Zhong Z, Yang M, et al. Development and clinical validation of novel 8-Gene prognostic signature associated with the proportion of regulatory T cells by weighted gene co-expression network analysis in uterine corpus endometrial carcinoma. Front Immunol. 2021;12: 788431.","journal-title":"Front Immunol."},{"key":"4191_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/iub.1467","volume":"68","author":"X Miao","year":"2016","unstructured":"Miao X, Jia L, Zhou H, Song X, Zhou M, Xu J, et al. miR-4299 mediates the invasive properties and tumorigenicity of human follicular thyroid carcinoma by targeting ST6GALNAC4. IUBMB Life. 2016;68:136\u201344.","journal-title":"IUBMB Life."},{"issue":"1","key":"4191_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J Royal Stat Soc Ser B-methodol. 1996;58(1):267\u201388.","journal-title":"J Royal Stat Soc Ser B-methodol."},{"issue":"282","key":"4191_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457\u201381.","journal-title":"J Am Stat Assoc."},{"issue":"12","key":"4191_CR16","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods."},{"key":"4191_CR17","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"4191_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13238-020-00741-7","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ten Dijke P, Wuhrer M, Zhang T. Role of glycosylation in TGF-\u03b2 signaling and epithelial-to-mesenchymal transition in cancer. Protein Cell. 2021;12:89\u2013106.","journal-title":"Protein Cell."},{"key":"4191_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/ni.3552","volume":"17","author":"R Beatson","year":"2016","unstructured":"Beatson R, Tajadura-Ortega V, Achkova D, Picco G, Tsourouktsoglou TD, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273\u201381.","journal-title":"Nat Immunol."},{"key":"4191_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1158\/2326-6066.CIR-19-0514","volume":"8","author":"M Kvorjak","year":"2020","unstructured":"Kvorjak M, Ahmed Y, Miller ML, Sriram R, Coronnello C, Hashash JG, et al. Cross-talk between colon cells and macrophages increases ST6GALNAC1 and MUC1-sTn expression in ulcerative colitis and colitis-associated colon cancer. Cancer Immunol Res. 2020;8:167\u201378.","journal-title":"Cancer Immunol Res."},{"key":"4191_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/cancers14030645","volume":"14","author":"N Berois","year":"2022","unstructured":"Berois N, Pittini A, Osinaga E. Targeting tumor glycans for cancer therapy: successes, limitations, and perspectives. Cancers. 2022;14:645.","journal-title":"Cancers"},{"key":"4191_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nri.2018.3","volume":"18","author":"E Rodr\u00cdguez","year":"2018","unstructured":"Rodr\u00cdguez E, Schetters STT, van Kooyk Y. The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nat Rev Immunol. 2018;18:204\u201311.","journal-title":"Nat Rev Immunol."},{"key":"4191_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tibtech.2018.10.001","volume":"37","author":"D Laaf","year":"2019","unstructured":"Laaf D, Bojarov\u00e1 P, Elling L, K\u0159en V. Galectin-carbohydrate interactions in biomedicine and biotechnology. Trends Biotechnol. 2019;37:402\u201315.","journal-title":"Trends Biotechnol."},{"key":"4191_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1158\/0008-5472.CAN-18-2244","volume":"79","author":"L Vuong","year":"2019","unstructured":"Vuong L, Kouverianou E, Rooney CM, McHugh BJ, Howie SEM, Gregory CD, et al. An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to pd-l1 blockade. Cancer Res. 2019;79:1480\u201392.","journal-title":"Cancer Res."},{"key":"4191_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J. TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol. 2012;13:616\u201330.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4191_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.gastro.2017.09.007","volume":"154","author":"J Chen","year":"2018","unstructured":"Chen J, Zaidi S, Rao S, Chen JS, Phan L, Farci P, et al. Analysis of genomes and transcriptomes of hepatocellular carcinomas identifies mutations and gene expression changes in the transforming growth factor-\u03b2 pathway. Gastroenterology. 2018;154:195\u2013210.","journal-title":"Gastroenterology."},{"key":"4191_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrgastro.2012.114","volume":"9","author":"A Majumdar","year":"2012","unstructured":"Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, et al. Hepatic stem cells and transforming growth factor \u03b2 in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012;9:530\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"4191_CR28","first-page":"288","volume":"7","author":"ZZ Dong","year":"2008","unstructured":"Dong ZZ, Yao DF, Yao M, Qiu LW, Zong L, Wu W, et al. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2008;7:288\u201395.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"4191_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022129","volume":"9","author":"YE Zhang","year":"2017","unstructured":"Zhang YE. Non-Smad signaling pathways of the TGF-\u03b2 family. Cold Spring Harbor Perspect Biol. 2017;9: a022129.","journal-title":"Cold Spring Harbor Perspect Biol."},{"key":"4191_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","volume":"19","author":"CJ David","year":"2018","unstructured":"David CJ, Massagu\u00e9 J. Contextual determinants of TGF\u03b2 action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19:419\u201335.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4191_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ki.2013.95","volume":"84","author":"MA Venkatachalam","year":"2013","unstructured":"Venkatachalam MA, Weinberg JM. New wrinkles in old receptors: core fucosylation is yet another target to inhibit TGF-\u03b2 signaling. Kidney Int. 2013;84:11\u20134.","journal-title":"Kidney Int."},{"key":"4191_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20111923","volume":"445","author":"YW Kim","year":"2012","unstructured":"Kim YW, Park J, Lee HJ, Lee SY, Kim SJ. TGF-\u03b2 sensitivity is determined by N-linked glycosylation of the type II TGF-\u03b2 receptor. Biochem J. 2012;445:403\u201311.","journal-title":"Biochem J."},{"key":"4191_CR33","doi-asserted-by":"publisher","first-page":"F1017","DOI":"10.1152\/ajprenal.00426.2010","volume":"300","author":"H Lin","year":"2011","unstructured":"Lin H, Wang D, Wu T, Dong C, Shen N, Sun Y, et al. Blocking core fucosylation of TGF-\u03b21 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol. 2011;300:F1017-25.","journal-title":"Am J Physiol Renal Physiol."},{"key":"4191_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13058-017-0904-8","volume":"19","author":"CF Tu","year":"2017","unstructured":"Tu CF, Wu MY, Lin YC, Kannagi R, Yang RB. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-\u03b2 receptor core fucosylation. Breast Cancer Res. 2017;19:111.","journal-title":"Breast Cancer Res."},{"key":"4191_CR35","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1102109","volume":"306","author":"EA Partridge","year":"2004","unstructured":"Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 2004;306:120\u20134.","journal-title":"Science."},{"key":"4191_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/bjc.2013.699","volume":"110","author":"M Hirakawa","year":"2014","unstructured":"Hirakawa M, Takimoto R, Tamura F, Yoshida M, Ono M, Murase K, et al. Fucosylated TGF-\u03b2 receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br J Cancer. 2014;110:156\u201363.","journal-title":"Br J Cancer."},{"key":"4191_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1559-0275-11-8","volume":"11","author":"J Ma","year":"2014","unstructured":"Ma J, Hart GW. O-GlcNAc profiling: from proteins to proteomes. Clin Proteomics. 2014;11:8.","journal-title":"Clin Proteomics."},{"key":"4191_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/tan.12900","volume":"88","author":"C Fu","year":"2016","unstructured":"Fu C, Zhao H, Wang Y, Cai H, Xiao Y, Zeng Y, et al. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen. Hla. 2016;88:275\u201386.","journal-title":"Hla."},{"key":"4191_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2017.03.002","volume":"44","author":"L Oliveira-Ferrer","year":"2017","unstructured":"Oliveira-Ferrer L, Legler K, Milde-Langosch K. Role of protein glycosylation in cancer metastasis. Semin Cancer Biol. 2017;44:141\u201352.","journal-title":"Semin Cancer Biol."},{"key":"4191_CR40","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15:540\u201355.","journal-title":"Nat Rev Cancer."},{"key":"4191_CR41","doi-asserted-by":"publisher","first-page":"E4066","DOI":"10.1073\/pnas.1406619111","volume":"111","author":"P Radhakrishnan","year":"2014","unstructured":"Radhakrishnan P, Dabelsteen S, Madsen FB, Francavilla C, Kopp KL, Steentoft C, et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc Natl Acad Sci U S A. 2014;111:E4066-75.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"4191_CR42","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1038\/s41467-018-05795-0","volume":"9","author":"JG Sweeney","year":"2018","unstructured":"Sweeney JG, Liang J, Antonopoulos A, Giovannone N, Kang S, Mondala TS, et al. Loss of GCNT2\/I-branched glycans enhances melanoma growth and survival. Nat Commun. 2018;9:3368.","journal-title":"Nat Commun."},{"key":"4191_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.acr.2014.11.002","volume":"126","author":"MR Kudelka","year":"2015","unstructured":"Kudelka MR, Ju T, Heimburg-Molinaro J, Cummings RD. Simple sugars to complex disease-mucin-type O-glycans in cancer. Adv Cancer Res. 2015;126:53\u2013135.","journal-title":"Adv Cancer Res."},{"key":"4191_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s004280050375","volume":"434","author":"Y Cao","year":"1999","unstructured":"Cao Y, Karsten U, Otto G, Bannasch P. Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and alpha2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch. 1999;434:503\u20139.","journal-title":"Virchows Arch."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04191-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04191-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04191-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:54:30Z","timestamp":1729670070000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04191-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04191-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"5 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Ethics Committee for Laboratory Animals of the First Affiliated Hospital of Zhejiang University. This research was approved by the Ethical Review Committee of this hospital. Written informed consent was received according to the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent for publication"}},{"value":"The authors have declared no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}